References
1. Du, Z.Q., et al., Clinical Charateristics and Outcome of Pyogenic Liver Abscess with Different Size: 15-Year Experience from a Single Center. Sci Rep, 2016. 6 : p. 35890.
2. Luo, M., et al., Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis. Eur J Clin Microbiol Infect Dis, 2016. 35 (10): p. 1557-65.
3. Pang, T.C., et al., Pyogenic liver abscess: an audit of 10 years’ experience. World J Gastroenterol, 2011. 17 (12): p. 1622-30.
4. Rahimian, J., et al., Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis, 2004. 39 (11): p. 1654-9.
5. Qian, Y., et al., A retrospective study of pyogenic liver abscess focusing on Klebsiella pneumoniae as a primary pathogen in China from 1994 to 2015. Sci Rep, 2016. 6 : p. 38587.
6. Zhang, S., et al., Clinical, microbiological, and molecular epidemiological characteristics of Klebsiella pneumoniae-induced pyogenic liver abscess in southeastern China. Antimicrob Resist Infect Control, 2019. 8 : p. 166.
7. Mukthinuthalapati, V., et al., Risk Factors, Management, and Outcomes of Pyogenic Liver Abscess in a US Safety Net Hospital. Dig Dis Sci, 2020. 65 (5): p. 1529-1538.
8. Serraino, C., et al., Characteristics and management of pyogenic liver abscess: A European experience. Medicine (Baltimore), 2018. 97 (19): p. e0628.
9. Yu, S.C., et al., Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Hepatology, 2004. 39 (4): p. 932-8.
10. Vogl, T.J. and F. Estifan, [Pyogenic liver abscess: interventional versus surgical therapy: technique, results and indications]. Rofo, 2001. 173 (7): p. 663-7.
11. Ferraioli, G., et al., Percutaneous and surgical treatment of pyogenic liver abscesses: observation over a 21-year period in 148 patients. Dig Liver Dis, 2008. 40 (8): p. 690-6.
12. Chen, Y.C., et al., Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the National Health Insurance Research Database of Taiwan, 2000-2011. J Microbiol Immunol Infect, 2016. 49 (5): p. 646-653.
13. Giangiuli, S.E., S.W. Mueller, and M.N. Jeffres, Transition to Oral versus Continued Intravenous Antibiotics for Patients with Pyogenic Liver Abscesses: A Retrospective Analysis. Pharmacotherapy, 2019.39 (7): p. 734-740.
14. He, S., et al., Percutaneous fine-needle aspiration for pyogenic liver abscess (3-6 cm): a two-center retrospective study. BMC Infect Dis, 2020. 20 (1): p. 516.
15. Lee, C.H., et al., Maximal diameter of liver abscess independently predicts prolonged hospitalization and poor prognosis in patients with pyogenic liver abscess. BMC Infect Dis, 2021.21 (1): p. 171.
16. Livingston, L.V. and E. Perez-Colon, Streptococcus intermedius Bacteremia and Liver Abscess following a Routine Dental Cleaning. Case Rep Infect Dis, 2014. 2014 : p. 954046.
17. Lardière-Deguelte, S., et al., Hepatic abscess: Diagnosis and management. J Visc Surg, 2015. 152 (4): p. 231-43.
18. Mezhir, J.J., et al., Current management of pyogenic liver abscess: surgery is now second-line treatment. J Am Coll Surg, 2010.210 (6): p. 975-83.
19. Thomsen, R.W., P. Jepsen, and H.T. Sørensen, Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis, 2007.44 (9): p. 1194-201.
20. Li, W., et al., A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases.BMC Gastroenterol, 2018. 18 (1): p. 144.
21. Du, Z., et al., Effect of diabetes mellitus on short-term prognosis of 227 pyogenic liver abscess patients after hospitalization.BMC Infect Dis, 2020. 20 (1): p. 145.
22. Ko, M.C., et al., A cohort study of age and sex specific risk of pyogenic liver abscess incidence in patients with type 2 diabetes mellitus. Medicine (Baltimore), 2019. 98 (17): p. e15366.
23. Lee, S.W.H., et al., Comparative effectiveness of telemedicine strategies on type 2 diabetes management: A systematic review and network meta-analysis. Sci Rep, 2017. 7 (1): p. 12680.
24. Flodgren, G., et al., Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev, 2015. 2015 (9): p. Cd002098.
25. Guarino, M., et al., Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study. J Med Internet Res, 2020.22 (9): p. e20874.
26. Serper, M., et al., Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action? Hepatology, 2020.72 (2): p. 723-728.
27. Ming, W.K., et al., Telemedicine Technologies for Diabetes in Pregnancy: A Systematic Review and Meta-Analysis. J Med Internet Res, 2016. 18 (11): p. e290.
28. Tchero, H., et al., Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials.Telemed J E Health, 2019. 25 (7): p. 569-583.
29. K, C.S. and D. Sharma, Long-term follow-up of pyogenic liver abscess by ultrasound. Eur J Radiol, 2010. 74 (1): p. 195-8.
30. Dietrich, C.F., et al., Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol, 2020. 46 (10): p. 2579-2604.